A phase 1 pharmacokinetic, safety, and tolerability study of paclitaxel injection concentrate for nano-dispersion (PICN) administered once a week in subjects with advanced solid malignancies in Indian population.

Trial Profile

A phase 1 pharmacokinetic, safety, and tolerability study of paclitaxel injection concentrate for nano-dispersion (PICN) administered once a week in subjects with advanced solid malignancies in Indian population.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Aug 2016

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 21 Mar 2012 Additional lead trial investigator (Minish Jain) identified as reported by Clinical Trials Registry - India record.
    • 20 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top